ID   SL-15
AC   CVCL_Y285
DR   cancercelllines; CVCL_Y285
DR   DSMZ; ACC-955
DR   GEO; GSM866165
DR   Progenetix; CVCL_Y285
DR   Wikidata; Q54954819
RX   PubMed=16049984;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=16049984); ~30-40 hours (DSMZ=ACC-955).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-IGH (PubMed=16049984).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-955
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D19S433: 12,15
ST   D21S11: 30,31.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
RX   PubMed=16049984; DOI=10.1002/ijc.21348;
RA   Daibata M., Taguchi T., Nemoto Y., Iwasaki S., Ohtsuki Y., Taguchi H.;
RT   "In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying
RT   t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma
RT   with villous lymphocytes.";
RL   Int. J. Cancer 118:513-517(2006).
//